{
  "study_id": "NO16968",
  "study_title": "Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial",
  "table_name": "Baseline Patient Demographics",
  "table_title": "Baseline Patient Demographics",
  "description": "The requested table containing patient baseline demographics is not available in the provided document. The text on page 4 states, 'Treatment groups were well balanced in terms of baseline demographics and clinical characteristics (Data Supplement)', indicating the table is in a separate document not provided.",
  "footnotes": [],
  "groups": [
    {
      "name": "XELOX",
      "n": 944,
      "type": "intervention"
    },
    {
      "name": "FU/FA",
      "n": 942,
      "type": "intervention"
    }
  ],
  "characteristics": []
}